Search clinical trials for: Immune-related adverse event

Total 4906 results

Queensland Centre for Gynaecological Cancer
GlaxoSmithKline Research & Development Limited

Not yet recruiting

SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr) (SATELLITE)

Mmr Deficiency | Endometrial Cancer Stage I | Immune-related Adverse Event | Endometrioid Endometrial Adenocarcinoma

Australia
Chang Gung Memorial Hospital
Ministry of Science and Technology, Taiwan

Recruiting

Hyperpolarized 13C-MRI and Metabolomics for Immune-related Adverse Events (DNP_irAE)

Immune-related Adverse Event

Taiwan
Tom Appleton
Western University; Canadian Research Group in Immuno-Oncology

Not yet recruiting

Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis

Inflammatory Arthritis | Immune-related Adverse Event
Universitair Ziekenhuis Brussel

Recruiting

Food Intervention to Reduce Immunotherapy toXicity (FORX01)

Dietary Habits | Immune-related Adverse Event

Belgium
Centre Hospitalier Universitaire, Amiens
Central Hospital Saint Quentin

Recruiting

Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment (Ibe2i-TIPCI)

Immunotherapy | Immune Checkpoint Inhibitors | Immune-related Adverse Event | Predictive Biomarkers

France
Institut Mutualiste Montsouris

Recruiting

Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors (FAST-TRACK)

Cancer | Cardiovascular Complication | Immune Checkpoint Inhibitor | Immune-related Adverse Event

France
Algemeen Ziekenhuis Maria Middelares

Recruiting

Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors (CAVACI)

Cancer | Atherosclerosis | Cardiotoxicity | Diastolic Dysfunction | Immune Checkpoint Inhibitor-Related Myocarditis | Immune-related Adverse Event | Cardiac Abnormalities, Variable

Belgium
Lucie Heinzerling

Recruiting

Treatment of Immune-related Adverse Events Refractory to Standard Therapy and Associated Changes in Immunophenotype (PRIA)

Immune-related Adverse Event

Germany
AHS Cancer Control Alberta

Not yet recruiting

Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo) (IMPACT 1)

Diarrhea | Advanced Melanoma | Immune-related Adverse Event | Advanced Rectal Carcinoma

Canada
Diakonhjemmet Hospital
Oslo University Hospital; University Hospital of North Norway; Helse Nord-Trøndelag... and other collaborators

Recruiting

Rheumatic IMmune-Related Adverse Events in Patients Treated With Immune Check Point Inhibitors (RIMRA)

Immune-related Adverse Event

Norway
Manuela Eicher

Recruiting

ePRO-based Model of Care to Manage and Monitoring Symptoms of Cancer Patients Treated With Immune Checkpoint Inhibitors (IePRO)

Patient Reported Outcome Measures | Patient Safety

Switzerland
Assistance Publique - Hôpitaux de Paris

Recruiting

Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy. (PRONOSTIM)

Blood Cancer

France
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Recruiting

A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint Blockade

Immunotherapy | Pneumonitis, Interstitial | Immune-related Adverse Events

Belgium
Khashayar Esfahani

Recruiting

Tofacitinib for the Treatment of Refractory Immune-related Colitis From Checkpoint Inhibitor Therapy- TRICK Study

Immune-Mediated Colitis

Canada
Beijing Chao Yang Hospital

Recruiting

Discovery of Biomarkers Related to the Efficacy and Adverse Reactions of Immune Checkpoint Inhibitors Based on Metabolism-genomics

Cancer

China
University of Nottingham
Pfizer

Recruiting

Checkpoint Inhibitor-induced Liver Injury (ChILI)

Immune-Mediated Hepatitis

United Kingdom
Columbia University
Genentech, Inc.

Recruiting

Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)

Advanced Solid Tumor | Immune-related Adverse Events

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute

Recruiting

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Melanoma Stage IV | Melanoma Stage III | Drug Toxicity | Immune-related Adverse Event | Skin Cancer Stage III | Skin Cancer Stage IV | Drug-Induced Colitis

United States
Hospital Universitario Araba
Hospital Donostia; Hospital de Basurto; Complejo Hospitalario de Navarra; Hospital...

Recruiting

Autoantibodies in Treatment With Immune Checkpoint Inhibitors (AUTENTIC) (AUTENTIC)

Cancer | Metastatic Cancer | Solid Organ Cancer

Spain
Groupe Hospitalier Pitie-Salpetriere
Institut Curie

Completed

EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance Database (EXIT)

Cancer | Immune Checkpoint Inhibitor-Related Myocarditis | Immune-related Adverse Event

France
Duke University

Enrolling by invitation

Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy (IMBARC)

Cancer | Immune-related Adverse Event

United States
Institut Cancerologie de l'Ouest

Active, not recruiting

Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology (EDHITO)

Melanoma | Renal Cell Carcinoma | Head and Neck Cancer | Advanced Non-small Cell Lung Cancer | Immune Checkpoint Inhibitors | Therapeutic Patient Education | Immune-related Adverse Event

France
Claudia Spies

Completed

Comparison of Lormetazepam and Midazolam Used as Sedatives for Patients That Require Intensive Care

Sedation in Intensive Care Unit Patients

Germany
Biogen

Completed

A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT： Cohort Study

Acute Graft Versus Host Disease | Acute Kidney Injury | Stem Cell Transplant Complications | Major Adverse Cardiac Events
Eli Lilly and Company

Not yet recruiting

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Renal Function in Adults Living With Obesity (TRIUMPH-OUTCOMES)

Overweight and Obesity

United States, Canada, Australia, Germany, Mexico, Argentina, Brazil, Hungary, Austria, India, Poland, Slovakia, Spain, Netherlands, Turkey, Czechia, United Kingdom, Denmark, Puerto Rico, France, Israel
Fondazione IRCCS Istituto Nazionale dei Tumori,...
Politecnico di Milano

Recruiting

Improving the Success Rate for Thoracic Radiotherapy Through Specific Cardiac Substructure Dosimetry: Location Matters. (LOCATION MATTERS) (LM)

Locally Advanced Lung Non-Small Cell Carcinoma

Italy
Sichuan Provincial People's Hospital

Recruiting

Risk Factors and Risk Grading Prediction of Perioperative Respiratory Adverse Events in Children

Perioperative Respiratory Adverse Events

China
Shanghai Zhongshan Hospital
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University and other collaborators

Not yet recruiting

Predicting Adverse Kidney Events of Cardiac Surgery-Associated Acute Kidney Injury Using Novel Biomarkers

Critical Illness | Acute Kidney Injury | Kidney Failure

China
Cantonal Hospital of St. Gallen

Recruiting

Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment - a Collaborative Observational Research Project

Brain Tumor | Aneurysm | Disc Disease | Instabilities Lumbar

Switzerland
Seoul National University Hospital
Astellas Pharma Inc

Recruiting

Tacrolimus Exposure in Kidney Transplantation

Kidney Transplant Rejection

Korea, Republic of
AbbVie

Recruiting

A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer

United States
Centre Hospitalier Universitaire, Amiens

Recruiting

Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adverse Cardiovascular Events (MACE) in Peripheral Artery Disease (PAD) at Critical Ischaemia Stage (TAMIS)

Peripheral Artery Disease | Critical Limb Ischemia | Major Adverse Cardiovascular Events | Major Adverse Limb Events | Hemodynamic Measure

France
Zhujiang Hospital

Not yet recruiting

Effectiveness of Atorvastatin in Preventing Cerebrovascular Events After Flow Diverter Implantation

Efficacy Endpoint: no New Cerebrovascular Adverse Events Within 1 Year | Safety Endpoint: no New Moderate or Serious Adverse Events Within 1 Year | All-cause Mortality Events (Within 1 Year) | Incident Ischemic Stroke Events (Within 1 Year) | New Hemorrhagic Stroke Events (Within 1 Year) | New... and other conditions
Guangzhou FineImmune Biotechnology Co., LTD.

Recruiting

Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors (TAL-T)

Advanced Solid Tumor | Immunotherapy | Tumor Associated Lymph Node T Cell

China
University Hospital, Toulouse

Not yet recruiting

International Multicenter Project Comparing Radiofrequency Ablation Versus Implantable Defibrillator After Well-tolerated Ventricular Tachycardia in Ischemic Heart Disease With Minimally Impaired Ejection Fraction (VIVA)

Ischemic Heart Disease | Ventricular Tachycardia
Laval University
Ministere de la Sante et des Services Sociaux

Recruiting

Vaping Adverse Lung and Heart Events Cohort (VapALERT)

Electronic Cigarette Use | Vaping

Canada
AbbVie

Not yet recruiting

A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma
Eli Lilly and Company

Recruiting

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Elevated Lp(a) | Atherosclerotic Cardiovascular Disease (ASCVD)

Taiwan, United States, Spain, Argentina, China, Italy, Australia, France, Canada, Japan, Belgium, Denmark, Germany, Hungary, Israel, Austria, Korea, Republic of, Brazil, Mexico, Netherlands, Romania, United Kingdom, Greece, Czechia, India, Slovak... and more
Shandong Linglong Yingcheng Hospital

Recruiting

Protective Effect of Indocyanine Green Fluorescence Imaging Technology on Parathyroid Glands During Total Thyroidectomy

Indocyanine Green | Total Thyroidectomy | Parathyroid Function Low Adverse Event | Parathyroid Glands--Diseases

China
Jasper Gerritsen
Massachusetts General Hospital; Universitaire Ziekenhuizen KU Leuven; University... and other collaborators

Recruiting

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) (RECSUR)

Glioblastoma | Glioblastoma Multiforme | Recurrent Glioblastoma | Glioblastoma, IDH-wildtype | Glioblastoma Multiforme, Adult | Glioblastoma Multiforme of Brain | Astrocytoma of Brain | Astrocytoma, Malignant

United States, Germany, Netherlands, Switzerland, Belgium
Insel Gruppe AG, University Hospital Bern
Swiss Cancer League

Not yet recruiting

Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer (Ablatio)

Bile Duct Cancer

Switzerland
Beckman Coulter, Inc.

Recruiting

MACE CDS Software Master Enrollment Protocol

Cardiac Events

United States
AbbVie

Recruiting

A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

Ulcerative Colitis

United States
Université Catholique de Louvain
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Not yet recruiting

QSPainRelief-STRAT (QSPR-STRAT)

Chronic Pain | Analgesia | Adverse Drug Event | Drug Interaction
AbbVie

Recruiting

Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity in Adult Participants With Migraine (ECLIPSE)

Migraine

United Kingdom
Azienda Unità Sanitaria Locale Reggio Emilia

Recruiting

Rehabilitation Intervention to Prevent Adverse Events Related to Androgen-deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer (PCa): a Single Arm Feasibility Study (ReCaP Study) (ReCaP)

Rehabilitation | Metastatic Prostate Cancer (PCa) in ADT

Italy
AbbVie

Recruiting

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (LIVIGNO-4)

Non-Small Cell Lung Cancer

United States, Israel, Japan
Nantes University Hospital
Université de Nantes

Not yet recruiting

Patient Safety Incidents in Coordinated Primary Care Teams: a Multi-method Study (EVIDENS-Prim)

Adverse Event
Medical University Innsbruck

Not yet recruiting

Anticoagulation and Inflammation Monitoring in Patients After Heart and Vascular Interventions (PAC-AIM)

Delirium | Heart Surgery | Vascular Surgery | Hyperinflammatory Syndrome

Austria

Search clinical trials for: Immune-related adverse event

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations